LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 2 von insgesamt 2

Suchoptionen

  1. Artikel ; Online: Targeting EGFR degradation by autophagosome degraders.

    Zhu, ZhongFeng / Li, Jiaying / Shen, Shujun / Al-Furas, Hawaa / Li, Shengrong / Tong, Yichen / Li, Yi / Zeng, Yucheng / Feng, Qianyi / Chen, Kaiyue / Ma, Nan / Zhou, Fengtao / Zhang, Zhang / Li, Zhengqiu / Pang, Jiyan / Ding, Ke / Xu, Fang

    European journal of medicinal chemistry

    2024  Band 270, Seite(n) 116345

    Abstract: Several generations of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors have been developed for the treatment of non-small cell lung cancer (NSCLC) in clinic. However, emerging drug resistance mediated by new EGFR mutations or ... ...

    Abstract Several generations of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors have been developed for the treatment of non-small cell lung cancer (NSCLC) in clinic. However, emerging drug resistance mediated by new EGFR mutations or activations by pass, leads to malignant progression of NSCLC. Proteolysis targeting chimeras (PROTACs) have been utilized to overcome the drug resistance acquired by mutant EGFR, newly potent and selective degraders are still need to be developed for clinical applications. Herein, we developed autophagosome-tethering compounds (ATTECs) in which EGFR can be anchored to microtubule-associated protein-1 light chain-3B (LC3B) on the autophagosome with the assistance of the LC3 ligand GW5074. A series of EGFR-ATTECs have been designed and synthesized. Biological evaluations showed that these compounds could degrade EGFR and exhibited moderate inhibitory effects on certain NSCLC cell lines. The ATTEC 12c potently induced the degradation of EGFR with a DC
    Mesh-Begriff(e) Humans ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/pathology ; Lung Neoplasms/pathology ; Cell Proliferation ; Autophagosomes/metabolism ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Cell Line, Tumor ; ErbB Receptors ; Mutation ; Drug Resistance, Neoplasm
    Chemische Substanzen Protein Kinase Inhibitors ; ErbB Receptors (EC 2.7.10.1) ; EGFR protein, human (EC 2.7.10.1)
    Sprache Englisch
    Erscheinungsdatum 2024-03-26
    Erscheinungsland France
    Dokumenttyp Journal Article
    ZDB-ID 188597-2
    ISSN 1768-3254 ; 0009-4374 ; 0223-5234
    ISSN (online) 1768-3254
    ISSN 0009-4374 ; 0223-5234
    DOI 10.1016/j.ejmech.2024.116345
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: An overview of viral mutagenesis and the impact on pathogenesis of SARS-CoV-2 variants.

    Khan, Muhammad Zafar Irshad / Nazli, Adila / Al-Furas, Hawaa / Asad, Muhammad Imran / Ajmal, Iqra / Khan, Dildar / Shah, Jaffer / Farooq, Muhammad Asad / Jiang, Wenzheng

    Frontiers in immunology

    2022  Band 13, Seite(n) 1034444

    Abstract: Viruses are submicroscopic, obligate intracellular parasites that carry either DNA or RNA as their genome, protected by a capsid. Viruses are genetic entities that propagate by using the metabolic and biosynthetic machinery of their hosts and many of ... ...

    Abstract Viruses are submicroscopic, obligate intracellular parasites that carry either DNA or RNA as their genome, protected by a capsid. Viruses are genetic entities that propagate by using the metabolic and biosynthetic machinery of their hosts and many of them cause sickness in the host. The ability of viruses to adapt to different hosts and settings mainly relies on their ability to create
    Mesh-Begriff(e) Humans ; SARS-CoV-2/genetics ; COVID-19 ; Genome, Viral ; Viruses/genetics ; Mutagenesis
    Sprache Englisch
    Erscheinungsdatum 2022-11-28
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article ; Review
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2022.1034444
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang